Wyatt is an established computational biologist with more than 15 years of experience in development of a variety of microbiome technologies in multiple academic and industrial positions.
Nexilico and collaborators are awarded a grant to develop a new computational solution for reliable and cost-effective prediction of gut microbiome-mediated drug metabolism and its effect on drug efficacy and toxicity.
Nexilico's collaboration with Microvi Biotech Inc. on developing precision biological processes receives a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for $1.12M.
Nexilico, Inc. is selected by the National Institutes of Health, as one of the NIH SBIR awardees to exhibit their technology at the upcoming Biotechnology Innovation Organization (BIO) International Convention.
Nexilico, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct R&D work on the personalization of gut microbiome therapeutics.
Nexilico was selected to receive a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for $225,000 to develop a predictive platform for gut microbiome precision medicine.
Copyright © 2022 Nexilico, Inc. - All Rights Reserved.